Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. - Wikidata - wikimedia - TriplyDB

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.

http://www.wikidata.org/entity/Q34473958

about

Harnessing the protective potential of HIV-1 neutralizing antibodies Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion The HIV glycan shield as a target for broadly neutralizing antibodies Designing synthetic vaccines for HIV Antibody responses to envelope glycoproteins in HIV-1 infection Virological features associated with the development of broadly neutralizing antibodies to HIV-1 HIV broadly neutralizing antibody targets Synaptopodin couples epithelial contractility to α-actinin-4-dependent junction maturation Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein Recent Insights into the HIV/AIDS Pandemic.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.Antibody 10-1074 suppresses viremia in HIV-1-infected individuals Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer.

P2860

Q26766153-89D7A296-8B9E-4684-9CC7-0B2A15F8B7AE Q26772129-3BECA8FF-DE80-4610-B105-48D7DF3F9B84 Q26786540-14F018A3-E6AF-453A-AAE5-C1BF9A6424D4 Q26862617-6193084B-AF72-4969-A9F5-B50A009E6AE6 Q26991572-956F0C31-E2AF-4FA9-B5FD-C1F54A904558 Q27025177-23017AC3-0E6C-458F-BE0F-3EFC69B1966A Q27026662-2A4A88DA-6427-4F86-8BEE-91EDE68D595F Q27310572-3C9F6B73-E1F4-469F-843A-25B453C8D3DC Q27318151-206DE186-9888-4BDD-B759-0A4E86EB445A Q27319450-589AC61D-EEE3-42D7-B7F3-AE6761D7EDEE Q27644383-20EDA23A-A80A-4267-8CE6-FC0E2FB8A76D Q27644634-975DD7DC-65F6-4C7C-815A-432A2808F7C5 Q27644646-13934B36-404C-4BBD-BE3A-2CE39B2AEEB3 Q27654848-8B45D1E2-590B-4ECC-B3DC-BCDEA6D19573 Q28066335-8C748EB9-8B54-46D5-A539-047F011009A5 Q28075274-5AFE80DD-21B8-4E09-951B-EB38BC80DC3B Q28084672-50D3ADFC-331B-4F79-BF3A-41B84C597C6B Q28263063-3102CFDD-325F-4ACA-AA87-23DA08B78BFD Q28263932-D43D7975-906C-4B8E-8931-F577CA67376A Q28271300-D61556BD-6608-44DE-AA74-ED80A2B3914C Q28647225-0B473121-197F-41E7-AD70-AC25F685A98A Q29306052-262AAA17-4390-4D9D-BD0C-84BA888065D9 Q30235024-D855E73C-85EF-4B85-9EE3-2B85EFF85429 Q30393763-42D4EFFE-3DCF-447B-9005-75EFF2BCE418 Q33594304-3742B652-E157-4535-9E54-FE6CCC7A8D1D Q33620546-0EF3876F-76F6-47F3-8BDA-A9B822197F34 Q33711154-8349F956-FF05-428B-8CA4-E5B967AE6714 Q33753573-283B3504-6CE9-49F6-A3CA-56692A0E7E76 Q33786443-D63E5C22-8D9F-4610-942E-09DDECE819A7 Q34485027-68FFE4A2-D1BD-44E0-B87C-31F63E0CA30D Q34517381-81FD0FF2-6A76-420C-A3BA-8C701875101B Q34526404-1B767D28-9073-4AFB-AAD8-5B10D420855D Q34550046-05EBDAF7-96B6-4765-91B3-C74D061BAE33 Q34593860-BA5E7B02-8ECA-407E-A314-E1A998769CC3 Q34869927-594A1A7E-D7C9-4298-9977-517C8A8B9BEB Q35006601-A7AC6D68-917E-4FBB-9D95-0F48D9F80193 Q35076711-6C2D6EFA-9964-491D-9BF8-D35F999D8937 Q35110976-50CDFAF8-4A00-4648-A632-C624B8593C7D Q35119778-FFFDB246-8291-4052-94E1-F43A59CC11DD Q35217426-E3B2E2D9-C8F8-4124-B3E8-54C92B5DB0D1

P2860

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.

http://www.wikidata.org/entity/Q34473958

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@ast

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@en

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@nl

type

label

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@ast

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@en

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@nl

prefLabel

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@ast

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@en

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@nl

P1433

Q34473958-01287E61-D983-4442-8E8D-7FD26F74B207

P1476

Q34473958-22E950DB-E5A7-4619-A61C-ED1A972C6A45

P2093

Q34473958-0F045CE8-8045-4067-A540-73A9B73A109E

Q34473958-1824CBD8-39C0-4290-B57B-D806E2635917

Q34473958-1918877F-58D5-428E-993C-6C43A900AD6C

Q34473958-1ADA4438-E5A7-4CAD-A3B5-072ACFEB5A95

Q34473958-1C6CBA28-7A2C-4C7C-89E6-AFA167829415

Q34473958-1FD461BE-B95C-44E2-9AA7-02D726FABCB1

Q34473958-2DFC0278-3BEE-430D-9A50-E130F79B2591

Q34473958-423C690B-6289-4566-91C0-C2A744630C34

Q34473958-42E96065-1959-4B1F-A300-AFB4179E4FDE

Q34473958-4C621D14-E38F-4FB7-823C-8881B69DEE5E

P2860

Q34473958-18780D49-FF92-48D5-B567-C7D62340F2FB

Q34473958-1B492FE2-5B91-40A7-9A15-0F460D2B1382

Q34473958-1CC3A898-BE62-4EFC-9956-50D61FCCB295

Q34473958-1D4BD1E2-FBE6-46AA-8627-5E01AAFDFB1C

Q34473958-1E790B1B-2E92-4331-B8C6-E1FE3A216D46

Q34473958-1F71EB69-4688-4229-8C3B-1B0E77B48DCC

Q34473958-22A734B2-466D-49DF-A58E-496911AAA077

Q34473958-23C99AC3-7CA4-4C95-92FF-0A76FA2B9761

Q34473958-23D8EB1F-E86C-4F9C-AA8D-0F8785D953BC

Q34473958-2B69C202-F4EA-47C0-8B59-BF5DD992AFAC

P2888

Q34473958-3320D065-5A2B-459F-B981-1DB54A455859

P304

Q34473958-FF00A11E-D473-484D-8F36-A15034D00849

P31

Q34473958-14C26BCF-6566-45BF-8162-D2F44D2C89C2

P356

Q34473958-392BF0F6-989F-42C1-A4B7-B2559F2F5D9C

P407

Q34473958-C290975E-8BD0-484A-B7D3-FA2D80BBFBE1

P433

Q34473958-9EC18566-16C9-4895-90EE-83D974994826

P478

Q34473958-52255AEF-BA34-41D0-88A4-F31F041B1E71

P50

Q34473958-66832208-A2DB-46C3-B572-46EEB9717C6A

Q34473958-7ABF0484-E31B-4476-8AA8-12F9597AF969

Q34473958-82857B5F-A997-431E-829B-71BF17AE13DD

Q34473958-C2FC0AF7-D289-46A2-98C0-9F3213B7B358

P577

Q34473958-18F821C1-7250-4D5E-AF37-F529A017705A

P5875

Q34473958-E5A4C011-A2B7-4AF7-8977-052EA53702A7

P698

Q34473958-70079A21-3798-49EB-AAB3-F4E515796C8B

P921

Q34473958-645426C2-96AC-424A-A21A-8A7200E96181

P932

Q34473958-4D3A5B0E-4CF2-494B-AC4F-976617E73B73

P356

P1433

P1476

Broad and potent HIV-1 neutral ...... inds the gp41-gp120 interface.

@en

P2093

Alba Torrents de la Peña

http://www.w3.org/2001/XMLSchema#string

Aliaksandr Druz

http://www.w3.org/2001/XMLSchema#string

Andrew B Ward

http://www.w3.org/2001/XMLSchema#string

Byong H Kang

http://www.w3.org/2001/XMLSchema#string

Gwo-Yu Chuang

http://www.w3.org/2001/XMLSchema#string

Hiromi Imamichi

http://www.w3.org/2001/XMLSchema#string

Ivelin S Georgiev

http://www.w3.org/2001/XMLSchema#string

James M Binley

http://www.w3.org/2001/XMLSchema#string

Jinghe Huang

http://www.w3.org/2001/XMLSchema#string

Kwinten Sliepen

http://www.w3.org/2001/XMLSchema#string

P2860

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Molecular architecture of native HIV-1 gp120 trimers

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike

P2888

P304

138-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE13601

http://www.w3.org/2001/XMLSchema#string

P407

P433

7525

http://www.w3.org/2001/XMLSchema#string

P478

515

http://www.w3.org/2001/XMLSchema#string

P50

Marit J van Gils

P577

2014-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265344627

http://www.w3.org/2001/XMLSchema#string

P698

25186731

http://www.w3.org/2001/XMLSchema#string

P921

P932

4224615

http://www.w3.org/2001/XMLSchema#string